Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms

Androgen deprivation therapy targeting the androgens/androgen receptor (AR) signaling continues to be the mainstay treatment of advanced-stage prostate cancer. The use of second-generation antiandrogens, such as abiraterone acetate and enzalutamide, has improved the survival of prostate cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Shiv, Prajapati, Kumari Sunita, Kushwaha, Prem Prakash, Shuaib, Mohd, Kumar Singh, Atul, Kumar, Shashank, Gupta, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992566/
https://www.ncbi.nlm.nih.gov/pubmed/35582225
http://dx.doi.org/10.20517/cdr.2020.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992566/
https://www.ncbi.nlm.nih.gov/pubmed/35582225
http://dx.doi.org/10.20517/cdr.2020.45

Ejemplares similares